Crispr Therapeutics Deserves Attention After Positive CRISPR/Cas9 Patient DataSeeking Alpha • 12/11/20
Are Options Traders Betting on a Big Move in CRISPR Therapeutics (CRSP) Stock?Zacks Investment Research • 12/08/20
CRISPR Therapeutics and Vertex Present New Data for Investigational CRISPR/Cas9 Gene-Editing Therapy, CTX001™ at American Society of Hematology Annual Meeting and Exposition, Together With Publication in the New England Journal of MedicineGlobeNewsWire • 12/05/20
CRISPR Therapeutics AG (CRSP) CEO Samarth Kulkarni at Piper Sandler 32nd Annual Virtual Healthcare Conference (Transcript)Seeking Alpha • 12/02/20
CRISPR Therapeutics and Vertex to Host Investor Webcast to Review Data Presented at the 62nd American Society of Hematology Annual (ASH) Meeting and Exposition for Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001™ in Sickle Cell Disease and Beta ThGlobeNewsWire • 12/01/20
CRISPR Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare ConferenceGlobeNewsWire • 11/24/20
CRISPR Therapeutics to Participate in the Jefferies Virtual London Healthcare ConferenceGlobeNewsWire • 11/16/20
CRISPR/Cas9 Gene-Editing Therapy CTX001™ for Severe Hemoglobinopathies Accepted for Plenary Presentation at the 62nd American Society of Hematology (ASH) Meeting and ExpositionGlobeNewsWire • 11/04/20